BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 11344369)

  • 1. Ultrarush immunotherapy in patients with Hymenoptera venom allergy.
    Ruëff F; Przybilla B
    J Allergy Clin Immunol; 2001 May; 107(5):928-9. PubMed ID: 11344369
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety profile of hymenoptera venom immunotherapy (VIT) in monosensitized patients: lack of new sensitization to nontreated insect venom.
    Spoerl D; Bircher AJ; Scherer K
    J Investig Allergol Clin Immunol; 2011; 21(1):22-7. PubMed ID: 21370719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bee and wasp venom allergy].
    Przybilla B
    HNO; 1995 Jul; 43(7):451-62. PubMed ID: 7673005
    [No Abstract]   [Full Text] [Related]  

  • 4. Continuous immunotherapy for hymenoptera venom allergy using six month intervals.
    Baenkler HW; Meusser-Storm S; Eger G
    Allergol Immunopathol (Madr); 2005; 33(1):7-14. PubMed ID: 15777517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hymenoptera venom immunotherapy: Past, present, and future.
    Oppenheimer J; Golden DBK
    Ann Allergy Asthma Immunol; 2018 Sep; 121(3):276-277. PubMed ID: 29909053
    [No Abstract]   [Full Text] [Related]  

  • 6. [When can desensitization with bee and wasp venom be stopped?].
    Oei HD; Stroes ES; Beukema WP; van der Zwan JC
    Ned Tijdschr Geneeskd; 1991 Apr; 135(16):719-20. PubMed ID: 2038399
    [No Abstract]   [Full Text] [Related]  

  • 7. Hymenoptera Venom Allergy: How Does Venom Immunotherapy Prevent Anaphylaxis From Bee and Wasp Stings?
    Sahiner UM; Durham SR
    Front Immunol; 2019; 10():1959. PubMed ID: 31497015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bee and wasp venom allergy].
    Baumgartner A; Wokalek H; Schöpf E
    Fortschr Med; 1989 Jul; 107(21):460-3. PubMed ID: 2670712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of safety, risk factors and pretreatment methods during rush hymenoptera venom immunotherapy.
    Gorska L; Chelminska M; Kuziemski K; Skrzypski M; Niedoszytko M; Damps-Konstanska I; Szymanowska A; Siemińska A; Wajda B; Drozdowska A; Jutel M; Jassem E
    Int Arch Allergy Immunol; 2008; 147(3):241-5. PubMed ID: 18594155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Wasp and bee venom allergy].
    Knulst AC; de Maat-Bleeker F; Bruijnzeel-Koomen CA
    Ned Tijdschr Geneeskd; 1998 Apr; 142(16):889-92. PubMed ID: 9623183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rush Hymenoptera venom immunotherapy: successful treatment in a patient with systemic mast cell disease.
    Engler RJ; Davis WS
    J Allergy Clin Immunol; 1994 Sep; 94(3 Pt 1):556-9. PubMed ID: 8083461
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bee and wasp venom allergy].
    Przybilla B
    Hautarzt; 1993 Sep; 44(9):611-22; quiz 622-3. PubMed ID: 8407334
    [No Abstract]   [Full Text] [Related]  

  • 13. Rush Hymenoptera venom immunotherapy: a safe and practical protocol for high-risk patients.
    Sturm G; Kränke B; Rudolph C; Aberer W
    J Allergy Clin Immunol; 2002 Dec; 110(6):928-33. PubMed ID: 12464961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific ultrarush desensitization in Hymenoptera venom-allergic patients.
    Schiavino D; Nucera E; Pollastrini E; De Pasquale T; Buonomo A; Bartolozzi F; Lombardo C; Roncallo C; Patriarca G
    Ann Allergy Asthma Immunol; 2004 Apr; 92(4):409-13. PubMed ID: 15104191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunotherapy against hymenoptera venom: report of ten patients].
    Guzmán M MA; Salinas L J; Toche P P; Marinovic M MA; Gallardo O AM
    Rev Med Chil; 2007 Dec; 135(12):1566-71. PubMed ID: 18357358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse reactions in venom immunotherapy protocols: conventional versus ultra-rush.
    Selcuk A; Baysan A; Yesillik S; Demirel F; Kartal O; Gulec M; Musabak U; Sener O
    Ann Med; 2022 Dec; 54(1):2321-2325. PubMed ID: 36111408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Toxico-allergic reaction to wasp venom].
    Rogov VD
    Vestn Dermatol Venerol; 1985 Feb; (2):60-1. PubMed ID: 3993208
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunotherapy for Hymenoptera venom allergy compared with real-life stings: Are we doing our best?
    Pecoraro L; Giovannini M; Mori F; Saretta F; Barni S; Castagnoli R; Arasi S; Mastrorilli C; Liotti L; Caminiti L; Novembre E;
    Clin Exp Allergy; 2021 Feb; 51(2):209-211. PubMed ID: 33617014
    [No Abstract]   [Full Text] [Related]  

  • 19. Stinging insect allergy and venom immunotherapy.
    Gupta P; Greenberger PA
    Allergy Asthma Proc; 2004; 25(4 Suppl 1):S9-10. PubMed ID: 15515364
    [No Abstract]   [Full Text] [Related]  

  • 20. [Safety of rush immunotherapy with Hymenoptera venom].
    Sánchez-Morillas L; Reaño Martos M; Rodríguez Mosquera M; Iglesias Cadarso A; Domínguez Lázaro AR
    Allergol Immunopathol (Madr); 2005; 33(4):224-7. PubMed ID: 16045862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.